GLP-1 receptor agonists for obesity: eligibility across 99 countries

Lancet Diabetes Endocrinol. 2026 Feb;14(2):105-108. doi: 10.1016/S2213-8587(25)00356-0.
No abstract available

Publication types

  • Letter